2-methoxyisobutylisonitrile has been researched along with paclitaxel in 1 studies
Studies (2-methoxyisobutylisonitrile) | Trials (2-methoxyisobutylisonitrile) | Recent Studies (post-2010) (2-methoxyisobutylisonitrile) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
20 | 4 | 3 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aubert-Pouessel, A; BenoƮt, JP; Denizot, B; Garcion, E; Heurtault, B; Lamprecht, A; Menei, P; Paillard, A | 1 |
1 other study(ies) available for 2-methoxyisobutylisonitrile and paclitaxel
Article | Year |
---|---|
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Capsules; Drug Carriers; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Glioma; Male; Nanostructures; Nitriles; Paclitaxel; Rats; Rats, Inbred F344; RNA, Messenger | 2006 |